Clinical Trials Browser

Head and Neck Neoplasms, Stomatitis

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Stomatitis, Oral Ulcer

Neoplasms, Stomatitis

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Stomatitis

Head and Neck Neoplasms, Stomatitis

Head and Neck Neoplasms, Stomatitis

Squamous Cell Carcinoma of Head and Neck, Stomatitis

Head and Neck Neoplasms, Radiation Injuries, Stomatitis, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

Head and Neck Neoplasms, Stomatitis

Mouth Neoplasms, Stomatitis

Neoplasms, Stomatitis

Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Pain, Stomatitis

Head and Neck Neoplasms, Stomatitis, Mucositis

Inflammation, Neoplasms, Stomatitis

Stomatitis, Mucositis

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

Cataract, Multiple Myeloma, Neoplasms, Stomatitis

Leukemia, Stomatitis, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Graft vs Host Disease, Stomatitis, Hematologic Neoplasms

Head and Neck Neoplasms, Stomatitis, Mucositis

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Stomatitis

Sarcoma, Stomatitis

Clinical Trials

ARMOR

PREVLAR

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day

OMDP

Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy

Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC)

Brilacidin

Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis

A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer

OM

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma

A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

Cox-2 Inhibition in Radiation-induced Oral Mucositis

Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients

Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma

Efficacy of SNX-1012 in the Treatment of Oral Mucositis